SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

260 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 53,335,145 shares of 56,047,431 outstanding shares and own 95.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,994,226 shares), VANGUARD GROUP INC (5,454,555 shares), ARMISTICE CAPITAL, LLC (3,412,000 shares), DIMENSIONAL FUND ADVISORS LP (2,132,092 shares), MACQUARIE GROUP LTD (2,083,718 shares), STATE STREET CORP (1,777,662 shares), RENAISSANCE TECHNOLOGIES LLC (1,760,222 shares), GW&K Investment Management, LLC (1,573,411 shares), ASHFORD CAPITAL MANAGEMENT INC (1,231,228 shares), and Stephens Investment Management Group LLC (1,140,519 shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.